• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对金钱和生活质量的差异时间偏好。

Differential time preferences for money and quality of life.

作者信息

Parouty M B Y, Le H H, Krooshof D, Postma M J

机构信息

Department of Pharmacy, Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), University of Groningen, Groningen, the Netherlands.

出版信息

Pharmacoeconomics. 2014 Apr;32(4):411-9. doi: 10.1007/s40273-013-0124-8.

DOI:10.1007/s40273-013-0124-8
PMID:24464352
Abstract

BACKGROUND

This study provides an empirical investigation into differential time preferences between money and quality of life. Thus far, time preference investigations in health have mostly involved life-years gained and lives saved. However, the quality-adjusted life-year, which is recommended by several bodies, is a multiplicative measure of life duration and quality of life. To our knowledge, our study is the first to follow this approach specifically for quality of life.

METHODS

A questionnaire was developed to elicit time preferences for quality of life and for money, and it was distributed to a representative sample of the Dutch population. We also investigated the impact of population characteristics, such as current health state, optimistic/pessimistic future views or gender, on time preferences.

RESULTS

We found that discount rates for both money and quality of life decrease with increasing time of delay, with rates of the former being consistently at least two times higher than those of the latter. Similar trends in time preferences were observed across the subgroups, with the exception of the relatively high education subgroup.

CONCLUSION

In agreement with the results of other studies, our empirically derived discount rates are higher than the rates featured in national guidelines for health care economic assessment. Our empirical study adds to the evidence for differential discounting, both with regards to money and health, as well as in time.

摘要

背景

本研究对金钱和生活质量之间的差异时间偏好进行了实证调查。到目前为止,健康领域的时间偏好调查大多涉及获得的生命年数和挽救的生命。然而,几个机构推荐的质量调整生命年是生命时长和生活质量的乘积指标。据我们所知,我们的研究是首个专门针对生活质量采用这种方法的研究。

方法

设计了一份问卷来获取对生活质量和金钱的时间偏好,并将其分发给荷兰人口的代表性样本。我们还研究了人口特征,如当前健康状况、乐观/悲观的未来看法或性别,对时间偏好的影响。

结果

我们发现,金钱和生活质量的贴现率都随着延迟时间的增加而降低,前者的贴现率始终至少是后者的两倍。除了受教育程度相对较高的亚组外,各亚组的时间偏好都呈现出类似趋势。

结论

与其他研究结果一致,我们通过实证得出的贴现率高于医疗保健经济评估国家指南中的贴现率。我们的实证研究为金钱和健康方面以及时间方面的差异贴现提供了更多证据。

相似文献

1
Differential time preferences for money and quality of life.对金钱和生活质量的差异时间偏好。
Pharmacoeconomics. 2014 Apr;32(4):411-9. doi: 10.1007/s40273-013-0124-8.
2
Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time.回顾和试用降低贴现率的方法;在某个时间、某个地方的某个人。
Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):523-47. doi: 10.1586/14737167.2013.815404.
3
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy.成本效益分析中对健康影响的社会贴现:预期寿命的影响。
Pharmacoeconomics. 2005;23(8):791-802. doi: 10.2165/00019053-200523080-00005.
4
Advocating a Paradigm Shift in Health-State Valuations: The Estimation of Time-Preference Corrected QALY Tariffs.倡导健康状态估值范式转变:时间偏好校正 QALY 关税的估计。
Value Health. 2018 Aug;21(8):993-1001. doi: 10.1016/j.jval.2018.01.016. Epub 2018 Mar 21.
5
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).源自多发性硬化症患者的健康状态值,用于特定于疾病的偏好测量:多发性硬化症影响量表-八个维度-患者版(MSIS-8D-P)。
Value Health. 2018 Nov;21(11):1338-1345. doi: 10.1016/j.jval.2018.03.019. Epub 2018 Jun 19.
6
Discounting future health gains: an empirical enquiry into the influence of growing life expectancy.贴现未来健康收益:对不断延长的预期寿命影响的实证研究。
Health Econ. 2011 Jan;20(1):111-9. doi: 10.1002/hec.1578.
7
Private and social time preferences for health and money: an empirical estimation.健康与金钱的个人和社会时间偏好:一项实证估计。
Health Econ. 2001 Jun;10(4):351-6. doi: 10.1002/hec.599.
8
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.一种用于获取健康状态偏好的混合建模方法:葡萄牙 EQ-5D-5L 值集。
Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14.
9
Social time preferences for health and money elicited with a choice experiment.通过选择实验引出的健康和金钱的社会时间偏好。
Value Health. 2010 Jun-Jul;13(4):368-74. doi: 10.1111/j.1524-4733.2009.00681.x. Epub 2010 Jan 8.
10
Time preferences for health gains: an empirical investigation.健康收益的时间偏好:一项实证研究。
Health Econ. 1993 Oct;2(3):257-65. doi: 10.1002/hec.4730020309.

引用本文的文献

1
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices.重视药品和其他卫生技术的社会影响:当前最佳实践用户指南。
Forum Health Econ Policy. 2024 Nov 8;27(1):29-116. doi: 10.1515/fhep-2024-0014. eCollection 2024 Jun 1.
2
A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: whether a specific approach is justified to tackle the challenges?一项关于基因治疗经济评估中适当贴现率的系统评价:是否有特定方法可以解决这些挑战?
Int J Technol Assess Health Care. 2024 May 10;40(1):e23. doi: 10.1017/S0266462324000096.
3

本文引用的文献

1
Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time.回顾和试用降低贴现率的方法;在某个时间、某个地方的某个人。
Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):523-47. doi: 10.1586/14737167.2013.815404.
2
Accumulating evidence for the case of differential discounting.差别折扣案例的证据不断积累。
Expert Rev Clin Pharmacol. 2013 Jan;6(1):1-3. doi: 10.1586/ecp.12.73.
3
On discounting of health gains from human papillomavirus vaccination: effects of different approaches.从 HPV 疫苗接种中获得的健康收益的折扣:不同方法的影响。
Economic evaluation of meningococcal vaccines: considerations for the future.
脑膜炎球菌疫苗的经济学评价:未来的考虑因素。
Eur J Health Econ. 2020 Mar;21(2):297-309. doi: 10.1007/s10198-019-01129-z. Epub 2019 Nov 21.
4
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.降低慢性肾脏病的成本,同时提供优质的医疗保健:行动呼吁。
Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30.
5
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.疫苗健康经济评估方法与免疫决策框架:欧洲疫苗经济学共同体的共识框架
Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2.
Value Health. 2012 May;15(3):562-7. doi: 10.1016/j.jval.2012.01.005. Epub 2012 Mar 29.
4
Looking on the bright side: children's knowledge about the benefits of positive versus negative thinking.乐观向上:儿童对积极思维与消极思维益处的认知。
Child Dev. 2012 Mar-Apr;83(2):667-82. doi: 10.1111/j.1467-8624.2011.01706.x. Epub 2011 Dec 21.
5
Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination.常规婴儿接种后侵袭性肺炎球菌病流行病学的观察差异。
Expert Rev Vaccines. 2011 Feb;10(2):187-99. doi: 10.1586/erv.10.163.
6
Towards a healthier discount procedure.迈向更健康的折扣程序。
Expert Rev Pharmacoecon Outcomes Res. 2005 Feb;5(1):59-63. doi: 10.1586/14737167.5.1.59.
7
WHO Guide for standardisation of economic evaluations of immunization programmes.世卫组织免疫规划经济评估标准化指南。
Vaccine. 2010 Mar 8;28(11):2356-9. doi: 10.1016/j.vaccine.2009.06.035. Epub 2009 Jun 28.
8
Funding of drugs: do vaccines warrant a different approach?药物资金:疫苗是否需要不同的方法?
Lancet Infect Dis. 2008 Nov;8(11):727-33. doi: 10.1016/S1473-3099(08)70258-5.
9
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada.加拿大预防性人乳头瘤病毒疫苗的潜在成本效益
Vaccine. 2007 Jul 20;25(29):5399-408. doi: 10.1016/j.vaccine.2007.04.086. Epub 2007 May 22.
10
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.通过健康经济模型的网络界面为政策制定者提供强化决策支持——以荷兰全国范围内使用7价肺炎球菌结合疫苗进行婴儿疫苗接种的成本效益分析为例
Vaccine. 2007 May 4;25(18):3669-78. doi: 10.1016/j.vaccine.2007.01.088. Epub 2007 Feb 5.